A groundbreaking vaccine, designed entirely by artificial intelligence (AI), has been tested in humans for the first time, ...
15h
The AI‑designed vaccine that could stop the next pandemic successfully passes its first human trial
The treatment has proven safe in early testing and shows promise in providing immunity against multiple variants and future coronaviruses.
The goal is ambitious: a single vaccine that works not just against all known human coronavirus variants, but against related ...
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...
The new Novavax XBB.1.15 vaccine appears to have been knocked back for approval by the Therapeutic Goods Administration.
Analysis - Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was ...
This is the first human trial of an AI-designed vaccine. The results showed that this DNA vaccine was able to stimulate the ...
Merck also manufactures Ervebo, an Ebola vaccine approved for protection against the more common Zaire Ebola virus. Barr said ...
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
Jane Halton was in the room with the world’s top health chiefs as the World Health Organisation rang its most serious alarm ...
When the 2026 FIFA World Cup begins on June 11, 2026, matches will be played across 16 cities in the United States, Canada ...
After COVID cost South Africa deeply in lives and livelihoods, the idea of getting ahead of the curve rather than chasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results